Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2015, Article ID 120762, 5 pages
http://dx.doi.org/10.1155/2015/120762
Case Report

Pauci-Immune Necrotizing and Crescentic Glomerulonephritis with Membranous Lupus Nephritis, Fifteen Years after Initial Diagnosis of Secondary Membranous Nephropathy

1Department of Internal Medicine, William Beaumont Army Medical Center, 5005 N. Piedras Street, El Paso, TX 79920, USA
2Department of Nephrology, William Beaumont Army Medical Center, 5005 N. Piedras Street, El Paso, TX 79920, USA
3Department of Rheumatology, William Beaumont Army Medical Center, 5005 N. Piedras Street, El Paso, TX 79920, USA
4Nephrology Service, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA
5ProPath Services, LLP, 1355 River Bend Drive, Dallas, TX 75247, USA

Received 23 June 2015; Accepted 30 August 2015

Academic Editor: Kouichi Hirayama

Copyright © 2015 Ryan Burkhart et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Yu, Y. Tan, G. Liu, S.-X. Wang, W.-Z. Zou, and M.-H. Zhao, “Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis,” Kidney International, vol. 76, no. 3, pp. 307–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Hervier, M. Hamidou, J. Haroche, C. Durant, A. Mathian, and Z. Amoura, “Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?” Rheumatology International, vol. 32, no. 10, pp. 3285–3290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Nasr, V. D. D'Agati, H.-R. Park et al., “Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 3, pp. 682–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. N. Masani, L. J. Imbriano, V. D. D'Agati, and G. S. Markowitz, “SLE and rapidly progressive glomerulonephritis,” American Journal of Kidney Diseases, vol. 45, no. 5, pp. 950–955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Marshall, R. Dressier, and V. D'Agati, “Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis,” American Journal of Kidney Diseases, vol. 29, no. 1, pp. 119–124, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Lekkham, E. Bloom, and R. Rasib, “Membranous lupus nephritis with ANCA-associated crescentic glomerulonephritis in non-specific interstitial pneumonia [NKF abstract 173],” American Journal of Kidney Diseases, vol. 61, no. 4, p. B59, 2013. View at Google Scholar
  7. A. Chang, O. Aneziokoro, S. M. Meehan, and R. J. Quigg, “Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies,” Kidney International, vol. 71, no. 4, pp. 360–365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Stone, P. A. Merkel, R. Spiera et al., “Rituximab versus cyclophosphamide for ANCA-associated vasculitis,” The New England Journal of Medicine, vol. 363, no. 3, pp. 221–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. B. Jones, J. W. C. Tervaert, T. Hauser et al., “Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis,” The New England Journal of Medicine, vol. 363, no. 3, pp. 211–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Beck, A. S. Bomback, M. J. Choi et al., “KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis,” American Journal of Kidney Diseases, vol. 62, no. 3, pp. 403–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Walsh, F. Catapano, W. Szpirt et al., “Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis,” American Journal of Kidney Diseases, vol. 57, no. 4, pp. 566–574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. R. W. Jayne, G. Gaskin, N. Rasmussen et al., “Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis,” Journal of the American Society of Nephrology, vol. 18, no. 7, pp. 2180–2188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Nasr, S. M. Said, A. M. Valeri et al., “Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 2, pp. 299–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Specks, P. A. Merkel, P. Seo et al., “Efficacy of remission-induction regimens for ANCA-associated vasculitis,” The New England Journal of Medicine, vol. 369, no. 5, pp. 417–427, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. P. McAdoo and C. D. Pusey, “Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis?” Clinical Journal of the American Society of Nephrology, vol. 9, no. 4, pp. 641–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Fatima, E. D. Siew, J. P. Dwyer, and P. Paueksakon, “Membranous glomerulopathy with superimposed pauci-immune necrotizing crescentic glomerulonephritis,” Clinical Kidney Journal, vol. 5, no. 6, pp. 587–590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Shimada, T. Fujita, N. Nakamura et al., “A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy,” BMC Nephrology, vol. 14, article 73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. H. James, Y.-H. H. Lien, S. J. Ruffenach, and G. E. Wilcox, “Acute renal failure in membranous glomerulonephropathy: a result of superimposed crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 6, no. 6, pp. 1541–1546, 1995. View at Google Scholar · View at Scopus
  19. J. T. C. Kwan, R. H. Moore, S. M. Dodd, and J. Cunningham, “Crescentic transformation in primary membranous glomerulonephritis,” Postgraduate Medical Journal, vol. 67, no. 788, pp. 574–576, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Sen and D. A. Isenberg, “Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus,” Lupus, vol. 12, no. 9, pp. 651–658, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. P. A. Merkel, R. P. Polisson, Y. Chang, S. J. Skates, and J. L. Niles, “Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease,” Annals of Internal Medicine, vol. 126, no. 11, pp. 866–873, 1997. View at Publisher · View at Google Scholar · View at Scopus